Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial.

Source:http://linkedlifedata.com/resource/pubmed/id/15371831

Download in:

View as

General Info

PMID
15371831